×

Sign In

Search
Home

Crinetics Pharma’s hormonal disorder drug meets main goal in late-stage study

By Thomson Reuters Mar 19, 2024 | 5:09 AM

(Reuters) – Crinetics Pharmaceuticals said on Tuesday its experimental drug to treat a hormonal disorder met the main goal in a late-stage study.

(Reporting by Sneha S K; Editing by Shilpi Majumdar)

China's industrial profits post faster gains in June despite faltering economy

Olympics-South Korea expresses regret after its athletes introduced as North Korea at opening ceremony

China's H1 industrial profits rise 3.5% y/y

US union and Apple reach tentative labor agreement

Biden will announce Supreme Court reform plans on Monday, Politico reports

RFK Jr questions Trump's recent pro-crypto tone as the two vie for votes

Privacy Policy
Terms Of Service

Midwest Communications, Inc.

Copyright © 2024. All Rights Reserved.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.